CMS' 2025 Final Rule included an increased payment for Intrinsic Therapeutics' Barricaid device, according to a Nov. 12 news release.

A live webcast of the presentation will be available on the Events and Presentations section of Bicara’s website at www.bicara.com. An archived replay of the webcast will be available for ...

Bicara Therapeutics is a clinical-stage biopharmaceutical company ... potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and ...

QBE North America today announced the release of its 2024 Digital Health Insurance Report, which shares insights from insurance brokers on the risks associated with using digital health services like ...

QSC EMEA GmbH announces the launch of Q-SYS Reflect in Poland, Romania, Greece, Hungary, Czech Republic, Slovakia, Cyprus, Bulgaria, Estonia and Latvia. These new countries join the growing list of ...

HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Completed upsized initial public offering, raising approximately $362 million in gross proceeds, with full ...

Q3 2024 Earnings Call Transcript November 7, 2024 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Daniel Baker, M.D., will join Cue Biopharma's executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific officer (CSO ...

At this time, all participants are in a listen-only mode. Later, there will be a question-and-answer session, and instructions will be given at that time. Please note that today's call is being ...

Mind Medicine’s share price has responded very strongly to Q3 update that contained very little new information. Read why I ...

The flexible architecture, intrinsic potential for high affinity and specificity, small size and high stability of DARPins offer benefits to drug design over other currently available protein-based ...

Gamification uses extrinsic and intrinsic rewards to motivate users ... it is unsurprising that digital therapeutics and apps, which often leverage gamification, are gaining attention among ...